AGO-OVAR 28/ENGOT-ov57. Niraparib alone versus niraparib in combination with bevacizumab in patients with carboplatin-taxane-based chemotherapy in advanced ovarian cancer: a multicenter randomized phase III trial
Titel:
AGO-OVAR 28/ENGOT-ov57. Niraparib alone versus niraparib in combination with bevacizumab in patients with carboplatin-taxane-based chemotherapy in advanced ovarian cancer: a multicenter randomized phase III trial
Auteur:
Heitz, Florian Marth, Christian Henry, Stéphanie Reuss, Alexander Cibula, David Gaba Garcia, Lydia Colombo, Nicoletta Schmalfeld, Barbara de Gregorio, Nikolaus Wimberger, Pauline Hasenburg, Annette Sehouli, Jalid Gropp-Meier, Martina Schouten, Philip C Hahnen, Eric Hauke, Jan Polleis, Sandra Harter, Philipp
Verschenen in:
International journal of gynecological cancer
Paginering:
Jaargang 33 () nr. 12 pagina's 1966-1969
Jaar:
2023
Inhoud:
Uitgever:
IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ.